Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Frontiers in Oncology
|
May 6, 2021
Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components
Jean-Luc Raoul, Marie-Françoise Heymann, Frédéric Dumont, et al.
Cancer Letters
|
January 3, 2006
Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype
Maud Barbado, Laurence Preisser, Michele Boisdron-Celle, et al.
Molecular Diagnosis & Therapy
|
March 4, 2020
Somatic mRNA Analysis of BRCA1 Splice Variants Provides a Direct Theranostic Impact on PARP Inhibitors
Louise-Marie Chevalier, Amandine Billaud, Sabrina Fronteau, et al.
Annales De Pathologie
|
February 22, 2020
[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies]
Louise-Marie Chevalier, Amandine Billaud, Christophe Passot, et al.
Genome Medicine
|
November 9, 2021
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes
Amandine Billaud, Louise-Marie Chevalier, Paule Augereau, et al.
Molecular Cancer Therapeutics
|
November 24, 2006
Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance
Alain Morel, Michele Boisdron-Celle, Luc Fey, et al.
Harm Reduction Journal
|
January 20, 2021
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Salim Mezaache, Patrizia Carrieri, Laélia Briand-Madrid, et al.
Harm Reduction Journal
|
February 20, 2021
Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Salim Mezaache, Patrizia Carrieri, Laelia Briand-Madrid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer
Laurence Gamelin, Michele Boisdron-Celle, Remy Delva, et al.
Biogerontology
|
May 13, 2004
Gene expression in aging kidney and pituitary
Laurence Preisser, Laetitia Houot, Laurent Teillet, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Frontiers in Oncology
|
May 6, 2021
Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components
Jean-Luc Raoul, Marie-Françoise Heymann, Frédéric Dumont, et al.
Cancer Letters
|
January 3, 2006
Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype
Maud Barbado, Laurence Preisser, Michele Boisdron-Celle, et al.
Molecular Diagnosis & Therapy
|
March 4, 2020
Somatic mRNA Analysis of BRCA1 Splice Variants Provides a Direct Theranostic Impact on PARP Inhibitors
Louise-Marie Chevalier, Amandine Billaud, Sabrina Fronteau, et al.
Annales De Pathologie
|
February 22, 2020
[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies]
Louise-Marie Chevalier, Amandine Billaud, Christophe Passot, et al.
Genome Medicine
|
November 9, 2021
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes
Amandine Billaud, Louise-Marie Chevalier, Paule Augereau, et al.
Molecular Cancer Therapeutics
|
November 24, 2006
Clinical relevance of different dihydropyrimidine dehydrogenase gene single nucleotide polymorphisms on 5-fluorouracil tolerance
Alain Morel, Michele Boisdron-Celle, Luc Fey, et al.
Harm Reduction Journal
|
January 20, 2021
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Salim Mezaache, Patrizia Carrieri, Laélia Briand-Madrid, et al.
Harm Reduction Journal
|
February 20, 2021
Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Salim Mezaache, Patrizia Carrieri, Laelia Briand-Madrid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer
Laurence Gamelin, Michele Boisdron-Celle, Remy Delva, et al.
Biogerontology
|
May 13, 2004
Gene expression in aging kidney and pituitary
Laurence Preisser, Laetitia Houot, Laurent Teillet, et al.
Page
of 7